Average Co-Inventor Count = 5.92
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Kymab Limited (22 from 103 patents)
2. Medimmune Limited (3 from 541 patents)
3. F-star Therapeutics, Inc. (1 from 11 patents)
4. F-star Delta Limited (0 patent)
26 patents:
1. 12209128 - Anti-PD-L1 antibodies
2. 11965026 - Anti-PD-L1 and IL-2 cytokines
3. 11858996 - Anti-ICOS antibodies
4. 11773175 - Antibodies, uses and methods
5. 11753479 - Nucleic acids encoding anti-OX40L antibodies
6. 11629189 - Bispecific antibody for ICOS and PD-L1
7. 11440960 - TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in vivo
8. 11396550 - Methods of treating comprising administering anti-OX40L antibodies
9. 11214620 - Binding molecules binding PD-L1 and LAG-3
10. 10669342 - Anti-OX40L antibodies and methods of treating graft versus host disease
11. 10654935 - Methods of treating SLE with anti-OX40L antibodies
12. 10604576 - Antibodies and immunocytokines
13. 10259880 - Anti-LIGHT antibodies
14. 9957323 - Anti-ICOS antibodies
15. 9868789 - Synergistic combinations of OX40L antibodies for the treatment of GvHD